Prognostic value of neutrophil-to-lymphocyte ratio in mCRPC patients treated with abiraterone, enzalutamide and docetaxel: a retrospective single-center study. (2026). Archivio Italiano Di Urologia E Andrologia. https://doi.org/10.4081/aiua.2026.15630